Yuxiang Chen

PD-1/PD-L1 immune checkpoint blockade-based combinational treatment: Immunotherapeutic amplification strategies against colorectal cancer.

Linjiang Song, Chi Liu, Qinxiu Zhang, 2021, International immunopharmacology.

Blocking the Wnt/β-catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review)

Kai Deng, Mo Chen, Yuxiang Chen, 2022, International journal of oncology.

m6A-related lncRNA signature for predicting prognosis and immune response in head and neck squamous cell carcinoma.

Yanlin Huang, Sen Li, Jidong Yin, 2022, American journal of translational research.